butamben Report issue

Small molecule Experimental
ChEMBL DrugBank Drug Central KEGG MeSH PubChem

Active Ingredient History

NOW
  • Now
Butamben is a local anesthetic. It is the ester of 4-aminobenzoic acid and butanol. It is one of three components in the topical anesthetic Cetacaine. The onset of Cetacaine-produced anesthesia is rapid (approximately 30 seconds) and the duration of anesthesia is typically 30-60 minutes, when used as directed. This effect is due to the rapid onset, but short duration of action of Benzocaine coupled with the slow onset, but extended duration of Tetracaine HCI and bridged by the intermediate action of Butamben.   NCATS

Chemistry

  • SMILES: CCCCOC(=O)C1=CC=C(N)C=C1
  • InChIKey: IUWVALYLNVXWKX-UHFFFAOYSA-N
  • Mol. Mass: 193.2423
  • ALogP: 2.23
  • ChEMBL Molecules:
    butamben  
    None  
More Chemistry

Pharmacology

Alternative names

abbott-34842 | abbott brand of butamben picrate | butamben | butambene | butamben picrate | butanylcaine | butesin | butesine | butoform | butyl 4-aminobenzoate | butyl aminobenzoate | butylcaine | n-butyl-p-aminobenzoate | zyljectin

Organizations (2)

Research & Development (2)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (5)

Approved Indications (1)


 

Pain

Experimental Indications - Clinical Trial Phases 1-4 (5)


 

Chronic Pain ()

Pain ()

Pain, Procedural (Phase 4)

Tooth Abnormalities (Phase 4)

Wound Healing (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial Organizations: 2

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue